Biao Luo

Title: Innovations in Cancer Diagnosis by Biao Luo

Introduction

Biao Luo is an accomplished inventor based in Princeton, NJ, who has made significant contributions to the field of cancer research. His innovative work focuses on developing systems and methods for diagnosing a predisposition to colon cancer. With one patent to his name, Luo's research aims to enhance early detection and characterization of this prevalent disease.

Latest Patents

Luo's patent, titled "Systems and methods for diagnosing a predisposition to develop colon cancer," provides a novel approach to evaluating cell nuclei for the presence or quantity of gamma-H2AX foci. This method involves assessing nucleic acids for genomic instability and surrogates of double-strand DNA breaks, including key proteins such as ATM, ATR, and 53BP1. By sequencing or probing nucleic acids that include germline sequences of specific genes, Luo's invention aims to identify alterations that may predispose individuals to colon cancer.

Career Highlights

Biao Luo is affiliated with the Institute for Cancer Research, where he continues to advance his research in cancer diagnostics. His work is pivotal in understanding the genetic factors that contribute to colon cancer, thereby aiding in the development of targeted screening methods.

Collaborations

Luo collaborates with esteemed colleagues, including Greg H Enders and Mark D Andrake, who contribute to the research efforts at the Institute for Cancer Research. Their combined expertise enhances the potential impact of Luo's innovations in the field of cancer diagnosis.

Conclusion

Biao Luo's contributions to cancer research through his innovative patent demonstrate the importance of early detection in improving patient outcomes. His work continues to pave the way for advancements in diagnosing predispositions to colon cancer.